All Articles
The COVID-19 pandemic has had a profound impact on cancer care delivery in the United States. Although access to high-quality care has been compromised, the pandemic has also driven innovation, according to information presented at the 2020 ASCO Quality Care Symposium by experts who discussed recent healthcare transformations. Read More ›
Approximately 7 months after the coronavirus sparked social distancing measures and concerns about hospital capacity, new medical records data help shed light on the magnitude of the drop in hospital admissions and the more recent rebound in hospitalizations. These new data provide additional information to help assess the economic impact of the COVID-19 pandemic on hospitals and insurers and also provide more information to help assess the extent to which people are still delaying or forgoing care. Read More ›
We often relate infusion appointment scheduling to playing a game of Tetris, because most of the effort is focused on scheduling patients with appointments of varying lengths into all available resources in the center. Once every resource is scheduled into and there are no more gaps on any of the resources (ie, the Tetris board is completely covered), then no additional patients can be booked. Read More ›
Sotorasib, an investigational small-molecule inhibitor of the KRAS p.G12C mutation, demonstrated promising activity and encouraging safety in patients with advanced solid tumors, in particular those with non–small-cell lung cancer (NSCLC), in the preliminary phase 1 CodeBreaK 100 trial. Read More ›
Xevinapant, an investigational antagonist of IAPs (inhibitor of apoptosis proteins), prolonged overall survival (OS) in patients with locally advanced head and neck squamous-cell carcinoma (HNSCC) when added to chemoradiotherapy, according to an updated analysis of a phase 2 clinical trial that was presented at the 2020 European Society for Medical Oncology (ESMO) congress. Read More ›
When I was a medical student, one of the attending physicians told me a story about a 25-year veteran nurse known as “Nurse Patty,” who he had worked with when he was a resident. Although most of the employees at the hospital were outstanding, this particular nurse had a reputation for making decisions that were not always medically sound. All of the residents at the hospital knew that when Nurse Patty was on duty, they needed to keep a careful eye on their patients. However, because this nurse had been employed at the hospital for many years, no one—including her—thought she could ever be fired. Read More ›
Helping patients with cancer achieve optimal health status can present special challenges when their basic needs such as food security, housing, and transportation are not being met. If patients are experiencing such social influencers to health, they will often forgo healthcare or become noncompliant with treatment due to lack of resources. Implementing a community health worker program to complement clinical care can help provide compassionate care for the most vulnerable patients and lead to improved outcomes. Read More ›
The following clinical trials represent a selection of key studies currently recruiting patients with bladder cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›
The combination of dabrafenib and trametinib performs as well in the real world as in clinical trials in patients with BRAF V600-mutated advanced melanoma and brain metastases, but the medical need for patients with brain metastases remains high. Read More ›
The combination of ipilimumab and anti–PD-1 therapy showed efficacy comparable to clinical trial populations in patients with preexisting autoimmune disease and advanced melanoma. Read More ›